Non-cystic Fibrosis Bronchiectasis Treatment 2021 | Prominent Players, Pipeline Growth, Future Trends, Unmet Demands, Emerging Therapies: DelveInsight
April 13, 2021 20:20 ET
|
DelveInsight Business Research LLP
Los Angeles, USA, April 13, 2021 (GLOBE NEWSWIRE) -- Non-cystic Fibrosis Bronchiectasis Treatment 2021 | Prominent Players, Pipeline Growth, Future Trends, Unmet Demands, Emerging Therapies:...
CRISPR Therapies Pipeline Insights 2021: Analysis of Key Companies, Emerging Therapies, Recent Happenings and Futuristic Trends
April 12, 2021 20:30 ET
|
DelveInsight Business Research LLP
Los Angeles, USA, April 12, 2021 (GLOBE NEWSWIRE) -- CRISPR Therapies Pipeline Insights 2021: Analysis of Key Companies, Emerging Therapies, Recent Happenings and Futuristic Trends The leading...
Promising Treatment for Sepsis Enters Clinical Trials: A Pipeline Products Review by DelveInsight
April 08, 2021 20:00 ET
|
DelveInsight Business Research LLP
Los Angeles, USA , April 08, 2021 (GLOBE NEWSWIRE) -- Promising Treatment for Sepsis Enters Clinical Trials: A Pipeline Products Review by DelveInsight The Sepsis pipeline is robust, with...
DUB Inhibitors Pipeline Insights: Analysis of Emerging Therapies, Key Pharma Players and Novel Approaches
March 31, 2021 08:30 ET
|
DelveInsight Business Research LLP
Los Angeles, USA, March 31, 2021 (GLOBE NEWSWIRE) -- DUB Inhibitors Pipeline Insights: Analysis of Emerging Therapies, Key Pharma Players and Novel Approaches DUB Inhibitors represents a...
A myriad of drugs are in the pipeline for Ulcerative Colitis treatment: DelveInsight
March 30, 2021 20:40 ET
|
DelveInsight Business Research LLP
Los Angeles, USA, March 30, 2021 (GLOBE NEWSWIRE) -- A myriad of drugs are in the pipeline for Ulcerative Colitis treatment: DelveInsight The Ulcerative Colitis drug pipeline is robust with 100+...
Newer approaches for the management of Cholestatic Pruritus treatment outlook
March 25, 2021 20:20 ET
|
DelveInsight Business Research LLP
Los Angeles, USA, March 25, 2021 (GLOBE NEWSWIRE) -- Newer approaches for the management of Cholestatic Pruritus treatment outlook Cholestatic Pruritus clinical trials are ongoing with...
Gonorrhea Pipeline Analysis: Emerging Therapies and Key Companies Transforming the Gonorrhea Landscape
March 24, 2021 21:10 ET
|
DelveInsight Business Research LLP
Los Angeles, USA, March 24, 2021 (GLOBE NEWSWIRE) -- Gonorrhea Pipeline Analysis: Emerging Therapies and Key Companies Transforming the Gonorrhea Landscape Gonorrhea Pipeline report provides...
Alopecia Areata Clinical Trials Report: Pipeline Insight 2021 by DelveInsight
March 23, 2021 20:30 ET
|
DelveInsight Business Research LLP
Los Angeles, USA, March 23, 2021 (GLOBE NEWSWIRE) -- Alopecia Areata Clinical Trials Report: Pipeline Insight 2021 by DelveInsight The increasing R&D investments for strong Alopecia Areata...
Prostate Cancer Pipeline Insights: Comprehensive Analysis of Key Emerging Therapies and Pharmaceutical Companies
March 22, 2021 21:40 ET
|
DelveInsight Business Research LLP
Los Angeles, USA, March 22, 2021 (GLOBE NEWSWIRE) -- Prostate Cancer Pipeline Insights: Comprehensive Analysis of Key Emerging Therapies and Pharmaceutical Companies With over 900 key...
Novel Rheumatoid Arthritis drugs succeed in the clinical trials: A status report by DelveInsight
March 18, 2021 21:30 ET
|
DelveInsight Business Research LLP
Los Angeles, USA , March 18, 2021 (GLOBE NEWSWIRE) -- Novel Rheumatoid Arthritis drugs succeed in the clinical trials: A status report by DelveInsight The Rheumatoid Arthritis Pipeline is robust as...